Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?

Fig. 4

The concentration changes of serum proteins in the prediction of treatment responses. Biomarker concentrations were measured at treatment initiation (circles) and the early stage (squares), while clinical responses were evaluated at the end of treatment (triangles). The decrease in the levels of the listed biomarkers was associated with positive responses at the end of treatment. The references are provided in Additional file 2: Table S4, and the full names of biomarkers are listed in Additional file 2: Table S5. ECM extracellular matrix

Back to article page

Clinical Proteomics

ISSN: 1559-0275